Psychiatry and Neurology, Neurology · Billings, MT
NPI
1679671598
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
801 N 29th St
Billings, MT, 59101
Phone (406) 238-2500
Groups this clinician bills Medicare through
Medicare paid, 2024
$66K
1,411 services
Medicare patients, 2024
517
Average age 71
Drug cost, 2024
$994K
2,683 prescriptions
Company payments, 2025
$49.44
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Scott A Riggins was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 295 times for 235 patients. In total Scott A Riggins billed 1,411 services in 36 codes, and Medicare paid $66K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-02-22.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 295 | 235 | $11.82 | $3,487 |
| 99214 Office E&M - Established | Facility | 286 | 209 | $67.17 | $19K |
| 99213 Office E&M - Established | Facility | 214 | 185 | $45.66 | $9,771 |
| 95886 Electrical Nerve Conductivity | Facility | 139 | 131 | $30.71 | $4,268 |
| 95874 Musculoskeletal | Facility | 60 | 27 | $13.63 | $818 |
| 95983 Electrical Nerve Conductivity | Facility | 49 | 23 | $37.16 | $1,821 |
| 64616 Musculoskeletal | Facility | 45 | 18 | $105.06 | $4,728 |
| 95910 Electrical Nerve Conductivity | Facility | 35 | 35 | $69.84 | $2,444 |
| 95908 Electrical Nerve Conductivity | Facility | 34 | 34 | $44.80 | $1,523 |
| 64612 Musculoskeletal | Facility | 29 | 12 | $109.58 | $3,178 |
| 95911 Electrical Nerve Conductivity | Facility | 25 | 25 | $95.08 | $2,377 |
| 95909 Electrical Nerve Conductivity | Facility | 24 | 24 | $55.78 | $1,339 |
| 99204 Office E&M - New | Facility | 20 | 20 | $72.54 | $1,451 |
| 95806 Sleep Study | Facility | 19 | 19 | $33.59 | $638 |
| 95885 Electrical Nerve Conductivity | Facility | 12 | 12 | $9.37 | $112 |
By year: 2022 $52K for 836 services; 2023 $61K for 1,066 services; 2024 $66K for 1,411 services.
Medicare prescription drug claims, 2024
In 2024, the drug Scott A Riggins prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 335 prescriptions and refills. In total Scott A Riggins wrote 2,683 Medicare prescriptions that cost $994K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 335 | 753 | 108 | $14K |
| Lamotrigine Generic | 239 | 476 | 42 | $3,850 |
| Levetiracetam Generic | 202 | 379 | 50 | $6,296 |
| Gabapentin Generic | 145 | 272 | 37 | $1,550 |
| Clonazepam Generic | 110 | 130 | 19 | $809 |
| Ropinirole Hcl Generic | 81 | 112 | 15 | $548 |
| Topiramate Generic | 67 | 92 | 13 | $606 |
| Primidone Generic | 67 | 119 | 14 | $1,227 |
| Donepezil Hcl Generic | 66 | 147 | 20 | $585 |
| Clobazam Generic | 63 | 76 | Under 11 | $6,495 |
| Xcopri Cenobamate | 63 | 63 | 11 | $62K |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 58 | 115 | 17 | $2,173 |
| Emgality Pen Galcanezumab-Gnlm | 58 | 60 | Under 11 | $42K |
| Pregabalin Generic | 54 | 86 | 12 | $666 |
| Lacosamide Generic | 51 | 67 | 11 | $12K |
Brand drugs: 414 claims; generic drugs: 2,222 claims; opioid claims: 32.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Scott A Riggins $49.44 ($49.44 in general payments such as food, travel and fees) from 1 company. The largest payer was Abbvie Inc. with $49.44.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 2 | $49.44 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.